SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003767
Filing Date
2021-11-09
Accepted
2021-11-09 16:29:49
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ccxi-20210930.htm   iXBRL 10-Q 2676070
2 EX-10.1 ccxi-ex10_1.htm EX-10.1 61292
3 EX-31.1 ccxi-ex31_1.htm EX-31.1 14136
4 EX-31.2 ccxi-ex31_2.htm EX-31.2 14004
5 EX-32.1 ccxi-ex32_1.htm EX-32.1 10040
6 EX-32.2 ccxi-ex32_2.htm EX-32.2 10065
  Complete submission text file 0000950170-21-003767.txt   9244193

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ccxi-20210930_def.xml EX-101.DEF 140550
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ccxi-20210930_pre.xml EX-101.PRE 297812
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ccxi-20210930_lab.xml EX-101.LAB 424064
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ccxi-20210930_cal.xml EX-101.CAL 54389
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ccxi-20210930.xsd EX-101.SCH 52346
12 EXTRACTED XBRL INSTANCE DOCUMENT ccxi-20210930_htm.xml XML 1894974
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 211392676
SIC: 2834 Pharmaceutical Preparations